Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Chipscreen Biosciences submits IND to the NMPA for pivotal phase III study of chiauranib in SCLC

Jan. 12, 2021

Turning Point Therapeutics describes new RET inhibitors

Jan. 12, 2021

Shanghai Institute of Materia Medica discloses PRDX1 inhibitors

Jan. 12, 2021

Chinese investigators divulge EGFR inhibitors

Jan. 12, 2021

Ideaya submits IND for phase I evaluation of MAT2A inhibitor IDE-397

Jan. 11, 2021

Dana-Farber Cancer Institute patents EGFR allosteric inhibitors

Jan. 11, 2021

CARs with switches

Jan. 11, 2021

Pfizer and CTxT Pty synthesize KAT inhibitors

Jan. 8, 2021

Chinese researchers presents new SERCAs for breast cancer

Jan. 8, 2021

Beijing Reciproca Pharmaceuticals patents new CDK inhibitors

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...